INVIVO-4204, formerly known as Anticancer Agent-I, is a novel anticancer agent, showing most significant anti-cancer activity against prostate cancer cells with IC50 of 8.8 μM and 9.5 μM in PC-3 and DU-145 cells, respectively. INVIVO-4204 has CAS#1983924-20-4. The last 4 digital of CAS# is used in its name. References: Miyake H, Imai S, Tamura K, Sugiyama T, Furuse H, Ozono S, Fujisawa M. Comparison of Tyrosine Kinase Inhibitor Versus Mammalian Target of Rapamycin Inhibitor as Second-line Molecular-targeted Therapy for Patients with Poor-risk Metastatic Renal Cell Carcinoma. Anticancer Res. 2017 Mar;37(3):1523-1528. PubMed PMID: 28314328.

纯度：≥98%

CAS：1983924-20-4